Exosomes are nanosized extracellular vesicles (EVs) that show great promise in tissue
regeneration and injury repair as mesenchymal stem cell (MSC). MSC has been shown to …

Osteoporosis (OP), characterized by decreased bone mass and destruction of bone
microarchitecture, is the most common bone degenerative disease. Conventional treatments …

Mesenchymal stem cell-derived exosomes (MSC-exos), with its inherent capacity to
modulate cellular behavior, are emerging as a novel cell-free therapy for bone regeneration …

Engineered skin substitutes derived from human skin significantly reduce inflammatory
reactions mediated by foreign/artificial materials and are consequently easier to use for …

Glucocorticoid-induced osteonecrosis of the femoral head (GC-ONFH) is a serious bone
disease that often affects young individuals. Bone grafting combined with core …

OBJECTIVE: Osteoporosis is the most common bone metabolic disease. Exosome exerts a
crucial role in the development of multiple diseases. The aim of the study was to investigate …

As the global population ages, bone‐related diseases have increasingly become a major
social problem threatening human health. Exosomes, as natural cell products, have been …

The complex pathogenesis of osteoporosis includes excessive bone resorption, insufficient
bone formation and inadequate vascularization, a combination which is difficult to …

Exosomes (EXs) shed by mesenchymal stem cells (MSCs) are potent therapeutic agents
that promote wound healing and regeneration, but when used alone in vivo, their …

Background Angiogenesis and tissue repair in chronic non-healing diabetic wounds remain
critical clinical problems. Engineered MSC-derived exosomes have significant potential for …